The additional benefit of computed tomography in cancer patients: impacts of sarcopenia and cachexia on quality of life during chemotherapy.
Galtieri Otavio Cunha de MedeirosIlanna Marques Gomes da RochaAline MarcadentiRicardo Andrade BezerraErica Roberta BarbalhoCarlos Alves de Sousa JúniorAna Paula Trussardi FayhPublished in: Radiologia brasileira (2024)
Among patients with gastrointestinal cancer submitted to chemotherapy, the chemotherapy-induced decline in QoL does not seem to differ significantly between those with cachexia or sarcopenia, as classified by CT-measured muscle mass, and those without. However, CT-based muscle mass evaluation remains crucial for guiding customized intervention strategies. Integrating this evaluation in radiological reports can provide valuable insights for planning specific care, thus improving patient QoL during treatment.
Keyphrases
- computed tomography
- chemotherapy induced
- dual energy
- image quality
- positron emission tomography
- contrast enhanced
- skeletal muscle
- healthcare
- randomized controlled trial
- magnetic resonance imaging
- locally advanced
- papillary thyroid
- palliative care
- case report
- quality improvement
- radiation therapy
- chronic pain
- young adults
- pain management
- rectal cancer
- childhood cancer